Danyi Wang earned a bachelor’s degree in biopharmaceutical sciences from Wuhan University and a master’s degree in pharmacology from the Shanghai Institute of Materia Medica, Chinese Academy of Sciences. She has contributed to multiple research projects and published in leading academic journals. Currently, Danyi is a PhD student in biomedical sciences at the City University of Hong Kong, where her research focuses on in vivo CRISPR-based functional screening of cancer-related genes.